Daily Market Brief · Monday, 1 June 2026
Zhiditech (301503) acquires Fengxu International for RMB 152.29 million
Zhiditech's board unanimously approved the acquisition of Fengxu International, while *ST Quanwei (300716) warns of potential delisting due to negative profits.
71 material announcements from 55 companies
Today's market saw significant developments, particularly in acquisitions and regulatory warnings. Zhiditech Co., Ltd. (301503) made headlines with a major acquisition, while *ST Quanwei Co., Ltd. (300716) issued a risk warning regarding its stock listing.
Deals & Restructuring
- Zhiditech Co., Ltd. (301503): The company announced the acquisition of 100% equity in Fengxu International Investment Co., Ltd. for approximately RMB 152.29 million. This decision was made during the eighth meeting of the fourth board of directors and aims to enhance Zhiditech's international strategy.
- Juntin Hotel Co., Ltd. (301073): The company is progressing with a tender offer to acquire 29.99% of Hubei Cultural Tourism Group Co., Ltd., involving 58,315,869 shares at RMB 25.71 each.
- Zhongfu Technology Co., Ltd. (300692): The acquisition of Junke Zhengyuan (Beijing) Drug Research Co., Ltd. is underway, with an estimated total equity value of RMB 1 billion.
Regulatory & Governance
- Beijing E-hualu Information Technology Co., Ltd. (300212): The company is under investigation by the China Securities Regulatory Commission for information disclosure violations and announced a pre-reorganization debt claim declaration, with creditors required to submit claims by June 28, 2026.
- *ST Quanwei Co., Ltd. (300716): The company issued a risk warning about a possible termination of its stock listing due to negative audited profits and net assets for the last fiscal year, prompting caution among investors.
- *ST Lingnan Co., Ltd. (002717): The company reported significant risks related to its convertible bonds, including a net loss of approximately RMB 2.34 billion in 2025, raising concerns about potential delisting.
Other Notable Developments
- Haisco Pharmaceutical Group Co., Ltd. (002653): The company's subsidiary received FDA approval for Cipepofol Injection, marking a significant milestone as the first self-innovated intravenous anesthetic from China to gain such approval.
- Amoy Diagnostics Co., Ltd. (300685): Trading of the company's shares will be suspended due to a planned change of control by its controlling shareholder.
- Jiangsu Hualan New Pharmaceutical Material Co., Ltd. (301093): The company approved a RMB 205 million investment by its subsidiary to enhance its business structure.
- Hefei Hengxin Life Science and Technology Co., Ltd. (301501): The company re-signed a tripartite supervision agreement for fundraising projects, integrating funds into a new biodegradable product production base project.
- Yunnan Tin Co., Ltd. (000960): The board approved participation in an auction for 100% equity of Chifeng Dajingzi Tin Industry Co., Ltd., aiming to enhance domestic tin smelting capacity.
Investors should monitor these developments closely as they may impact market dynamics and company valuations.
In this brief
- Announcement of Resolutions from the Eighth Meeting of the Fourth Board of Directors
- Risk Warning Announcement Regarding Possible Termination of Company Stock Listing
- Announcement on the Company's Pre-Reorganization Debt Claim Declaration
- Progress Announcement on the Acquisition of Junke Zhengyuan Equity
- Announcement on the Progress of the Tender Offer
- Announcement on the FDA Approval of Cipepofol Injection
- Announcement on the Suspension of Trading Due to Planned Change of Company Control
- Announcement on the Expiration of the Tender Offer by Suzhou Zhuyue Hongzhi Technology Development Partnership (Limited Partnership) and Stock Suspension
- Report on the 13th Temporary Trustee Management Affairs for the Convertible Bonds Issued by Lingnan Ecological Culture and Tourism Co., Ltd. in 2026
- Announcement on the Purchase of 100% Equity of Fengxu International Investment Co., Ltd.
- Announcement by Zhongcheng Import and Export Co., Ltd. on Forming a Consortium for New Zealand Project and Accepting Related Party Guarantees
- Verification Opinion of Guotai Junan Securities Co., Ltd. on Zhuhai Zhiditech Co., Ltd.'s Change in Implementation Method of Certain Fundraising Projects
- Announcement on the Progress of Halting Personal Care Business
- Announcement on Using Surplus Reserves to Offset Losses and Notify Creditors
- Announcement on the Appointment of Senior Management Personnel
- Announcement of Resolutions from the Seventh Meeting of the Sixth Board of Directors
- Announcement on the Sale of 100% Equity of Wholly-Owned Subsidiary and Related Transactions
- Announcement of Abnormal Stock Trading Fluctuations
- Announcement on the Investment by Wholly-Owned Subsidiary
Jiangsu Hualan New Pharmaceutical Material Co., Ltd. (301093)
- Announcement of Resolutions from the 17th Meeting of the 6th Board of Directors
Jiangsu Hualan New Pharmaceutical Material Co., Ltd. (301093)
- Announcement on the Completion of the Board of Directors Election and Appointment of Senior Management Personnel
- Announcement on the Public Issuance of Subordinated Bonds (Phase II) by GF Securities Co., Ltd. for Professional Investors in 2026
- Announcement on the Company's Involvement in the Resolution to Withdraw Litigation
- Progress Announcement on the Implementation of Other Risk Warnings for Company Stock
- Announcement on Receiving the Administrative Penalty Decision from the Shanghai Regulatory Bureau of the China Securities Regulatory Commission
- Revised Prospectus for the Issuance of A Shares to Specific Targets and Listing on the ChiNext in 2025
- Supplementary Legal Opinion Letter from Anhui Tianhe Law Office on Anhui Zhongfu Yuanchuang Technology Group Co., Ltd. Issuing Shares to Specific Objects (Revised Draft) (Exempt Version)
- Prospectus for Issuance of Convertible Corporate Bonds (Registration Draft)
- Sponsorship Letter for Securities Issuance
- Announcement on Cumulative Litigation and Arbitration Situations
- Progress Announcement on the Implementation of Additional Risk Warnings for Company Stock
- Announcement on the Passive Formation of Related Transactions After Completing Equity Acquisition
- Announcement of Resolutions from the 15th Meeting of the 5th Board of Directors
- Zhejiang Merchants Securities Co., Ltd. on the Listing Sponsorship Letter for Shenzhen Huichuangda Technology Co., Ltd.'s Public Offering of Convertible Bonds (Revised Draft)
- Shenzhen Huichuangda Technology Co., Ltd. Prospectus for Issuing Convertible Bonds to Unspecified Objects (Draft) (Revised)
- Zhejiang Merchants Securities Co., Ltd. on the Issuance of Convertible Bonds by Shenzhen Huichuangda Technology Co., Ltd. (Revised Draft)
- Announcement on Recent Winning and Pre-winning Projects
- Notice on the Preliminary Winning Bid for the High-Voltage Prefabricated Substation Project
- Sponsorship Letter for Zhejiang Fengmao Technology Co., Ltd.'s Public Offering of Convertible Bonds (2025 Financial Data Update)
- Announcement of Resolutions from the First Extraordinary Shareholders' Meeting of 2026
- Management System for Foreign Exchange Hedging Business (June 2026)
- Sponsorship Letter for Shenzhen Amperelong Technology Co., Ltd.'s Stock Issuance to Specific Investors and Listing on the ChiNext Board
- Sponsorship Letter from Huatai United Securities Co., Ltd. for Shenzhen Amperlong Technology Co., Ltd.'s Specific Object Stock Issuance and Listing on the Growth Enterprise Market (Registration Draft)
- Tianyi Co., Ltd.: Notice on the Announcement of Candidate for Transaction
- Announcement on the Re-signing of the Tripartite Supervision Agreement for Fundraising Projects After Changes
Hefei Hengxin Life Science and Technology Co., Ltd. (301501)
- Announcement on Project Bid Winning
- Announcement of Resolutions from the Fifth Meeting of the Sixth Board of Directors
- Announcement on the Pledge of Shares by Actual Controller
- Announcement on Public Transfer of Equity in Affiliated Company
- First Notice on Early Redemption of Jinpu Convertible Bonds
- Announcement on the Progress of Major Contracts and Litigation Matters
- Announcement of Resolutions from the Second Meeting of the Fifth Board of Directors
- Announcement on the Approval of the Company's Raw Material Drug by CDE
- Progress Announcement on the Company's Investment with Related Parties to Establish a Holding Subsidiary and Related Transactions
- Announcement of Resolutions from the Third (Extraordinary) Meeting of the Seventh Board of Directors
- Announcement of Resolutions from the 23rd Meeting of the 2nd Board of Directors
- Announcement on the Progress of External Guarantees
- Announcement of Resolutions from the 9th Meeting of the 13th Board of Directors of Sichuan Huiyuan Optical Communication Co., Ltd.
- Announcement on Completion of Patient Enrollment for CKBA Cream Rosacea Phase IIa Clinical Trial and Early Launch of Phase IIb Clinical Trial
- Announcement of Resolutions from the 11th Meeting of the 4th Board of Directors
- Announcement on the Early Redemption of Jinpu Convertible Bonds
- Announcement on Termination of Planning for Change of Control and Resumption of Trading
- Important Notice on Early Redemption of Dier Convertible Bonds and Upcoming Suspension of Conversion
- Progress Announcement on Significant Matters of the Company
- Notice on the Ninth Reminder of Early Redemption of Keli Convertible Bonds
- Announcement on Abnormal Stock Trading Fluctuations
- Announcement on Signing Shipbuilding Contracts with Norwegian and Greek Shipowners
- Announcement of Resolutions from the Third Extraordinary Meeting of the 10th Board of Directors of Yunnan Tin Company Limited in 2026
- Announcement of Yunnan Tin Company Limited on Participating in the Auction for 100% Equity of Chifeng Dajingzi Tin Industry Co., Ltd.
- Announcement on the Sixth Reminder of Early Redemption of Ultrasonic Convertible Bonds by Ultrasonic Electronics
- Announcement on Abnormal Fluctuations in Stock Trading of Zhongcheng Import and Export Co., Ltd.
This brief is generated by AI from English translations of SZSE filings and may contain errors. It is for information only and is not investment advice.